These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 39191341)

  • 1. Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges.
    Jiang Y; Yan C; Li M; Chen S; Chen Z; Yang L; Luo K
    Int J Biol Macromol; 2024 Oct; 278(Pt 4):135072. PubMed ID: 39191341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of nanocarriers for natural products.
    Huang L; Luo S; Tong S; Lv Z; Wu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1967. PubMed ID: 38757428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges.
    Andreani T; Cheng R; Elbadri K; Ferro C; Menezes T; Dos Santos MR; Pereira CM; Santos HA
    Drug Deliv Transl Res; 2024 Oct; 14(10):2845-2916. PubMed ID: 39003425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.
    Aljuffali IA; Fang CL; Chen CH; Fang JY
    Curr Pharm Des; 2016; 22(27):4219-31. PubMed ID: 27323758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming Cancer Treatment with Nanotechnology: The Role of Berberine as a Star Natural Compound.
    Sun L; Lan J; Li Z; Zeng R; Shen Y; Zhang T; Ding Y
    Int J Nanomedicine; 2024; 19():8621-8640. PubMed ID: 39188860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
    Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
    Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
    Cadete A; Alonso MJ
    Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of marine polysaccharides to antitumor nanocarriers.
    Wang H; Hunter R; Zhang Q; Yu H; Wang J; Yue Y; Geng L; Wu N
    Carbohydr Polym; 2024 Oct; 342():122407. PubMed ID: 39048201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment.
    Abousalman-Rezvani Z; Refaat A; Dehghankelishadi P; Roghani-Mamaqani H; Esser L; Voelcker NH
    Adv Healthc Mater; 2024 May; 13(12):e2302902. PubMed ID: 38199238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
    Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
    Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier.
    Dey M; Das M; Chowhan A; Giri TK
    Int J Biol Macromol; 2019 Jun; 130():34-49. PubMed ID: 30779985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy.
    Li Q; Liu X; Yan C; Zhao B; Zhao Y; Yang L; Shi M; Yu H; Li X; Luo K
    Small; 2023 Jun; 19(23):e2206211. PubMed ID: 36890780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment.
    Wong KH; Lu A; Chen X; Yang Z
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32784890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyhydroxyalkanoates (PHAs) and its copolymer nanocarrier application in cancer treatment: An overview and challenges.
    Paul V; Pandhi S; Mahato DK; Agarwal A; Tripathi AD
    Int J Biol Macromol; 2024 Oct; 277(Pt 1):134201. PubMed ID: 39069052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
    Chakraborty S; Dhakshinamurthy GS; Misra SK
    J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.